It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

TY - JOUR

T1 - It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

AU - Oberle, Megan M.

AU - Kelly, Aaron S.

PY - 2019/10/29

Y1 - 2019/10/29

KW - GLP-1 receptor agonists

KW - adolescents

KW - obesity

KW - pedatrics

KW - type 2 diabetes

KW - weight management

UR - http://www.scopus.com/inward/record.url?scp=85075232897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075232897&partnerID=8YFLogxK

U2 - 10.3389/fendo.2019.00738

DO - 10.3389/fendo.2019.00738

M3 - Article

C2 - 31736876

AN - SCOPUS:85075232897

SN - 1664-2392

VL - 10

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

M1 - 738

ER -